Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma
Affiliations
- PMID: 32883335
- DOI: 10.1186/s12957-020-02010-7
Abstract
Background: Colon adenocarcinoma (COAD) is one of the most common malignant tumors, with high incidence and mortality rates worldwide. Reliable prognostic biomarkers are needed to guide clinical practice.
Methods: Comprehensive gene expression with alternative splicing (AS) profiles for each patient was downloaded using the SpliceSeq database from The Cancer Genome Atlas. Cox regression analysis was conducted to screen for prognostic AS events. The R package limma was used to screen differentially expressed genes (DEGs) between normal and tumor samples in the COAD cohort. A Venn plot analysis was performed between DEGs and prognostic AS events, and the DEGs that co-occurred with prognostic AS events (DEGAS) were identified. The top 30 most-connected DEGAS in protein-protein interaction analysis were identified through Cox proportional hazards regression to establish prognostic models.
Results: In total, 350 patients were included in the study. A total of 22,451 AS events were detected, of which 2004 from 1439 genes were significantly associated with survival time. By overlapping these 1439 genes with 6455 DEGs, 211 DEGs with AS events were identified. After the construction of the protein-protein interaction network, the top 30 hub genes were included in a multivariate analysis. Finally, a risk score based on 12 genes associated with overall survival was established (P < 0.05). The area under the curve was 0.782. The risk score was an independent predictor (P < 0.001).
Conclusions: By exploring survival-associated AS events, a powerful prognostic predictor consisting of 12 DEGAS was built. This study aims to propose a novel method to provide treatment targets for COAD and guide clinical practice in the future.
Keywords: Alternative splicing; Colon adenocarcinoma; Differentially expressed genes; Prognostic risk score.
Similar articles
- Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.J Cell Physiol. 2019 Dec;234(12):22753-22764. doi: 10.1002/jcp.28840. Epub 2019 May 29.PMID: 31140607 Free PMC article.
- Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.Cell Physiol Biochem. 2018;48(3):1355-1368. doi: 10.1159/000492094. Epub 2018 Jul 26.PMID: 30048970
- Screening TCGA database for prognostic genes in lower grade glioma microenvironment.Ann Transl Med. 2020 Mar;8(5):209. doi: 10.21037/atm.2020.01.73.PMID: 32309356 Free PMC article.
- A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.Int J Med Sci. 2020 Jul 19;17(13):1879-1896. doi: 10.7150/ijms.45813. eCollection 2020.PMID: 32788867 Free PMC article.
- INHBA is a prognostic predictor for patients with colon adenocarcinoma.BMC Cancer. 2020 Apr 15;20(1):305. doi: 10.1186/s12885-020-06743-2.PMID: 32293338 Free PMC article.
No hay comentarios:
Publicar un comentario